May 2, 2005 Five years ago, J. Craig Venter, legendary CEO of Celera, stood alongside Francis Collins from the federally-financed Human Genome project and accepted President Clinton’s congratulations for delineating the DNA sequences of the human genome. New horizons were seen. Paradigms shifted. Congratulations ensued. Celera’s stock price hit $250 a share. Now, Celera has donated its database to the government, which will give it away for free. What does this mean for Celera? More details...
